AG
Asthika Goonewardene Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
17
Avg Return
Past Year
Past Year
19%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
81.3%
Neutral
18.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Downgraded
| $120 |
4%
upside
| 1 | -15% |
–
| 24 Feb ‘26 3 months ago |
|
|
|
Buy
Initiated
| $40 |
75%
upside
| 1 | -8.5% |
0
%
| 17 Dec ‘25 6 months ago |
|
|
|
Buy
Initiated
| $43 |
42%
upside
| 1 | +15% |
0
%
| 25 Nov ‘25 6 months ago |
|
|
|
Hold
Downgraded
| $30.75 |
6%
upside
| 3 | +8.4% |
0
%
| 13 Nov ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $48 |
98%
upside
| 2 | +16% |
0
%
| 7 Nov ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $145 |
16%
upside
| 2 | +15% |
0
%
| 3 Nov ‘25 7 months ago |
|
|
|
Buy
Reiterated
| $39 |
63%
upside
| 1 | +57% |
0
%
| 7 Oct ‘25 8 months ago |
|
|
|
Hold
Downgraded
| $97 |
8%
upside
| 1 | – |
–
| 29 Sep ‘25 8 months ago |
|
|
|
Buy
Initiated
| $100 |
623%
upside
| 1 | -41% |
0
%
| 10 Sep ‘25 9 months ago |
|
|
|
Buy
Initiated
| $99 |
37%
downside
| 1 | +154% |
0
%
| 5 Sep ‘25 9 months ago |
|
|
|
Buy
Maintained
| $49 |
8%
downside
| 3 | +0.96% |
0
%
| 29 Jul ‘25 10 months ago |
|